• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

56.97 +0.65 (+1.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,457,864
Open 56.74
Bid (Size) 55.00 (2)
Ask (Size) 59.00 (1)
Prev. Close 56.32
Today's Range 56.20 - 58.79
52wk Range 29.31 - 59.39
Shares Outstanding 95,640,600
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Levi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 17, 2025 - CYTK
October 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Levi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 17, 2025 - CYTK
October 03, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit

Performance

YTD
+16.4%
+16.4%
1 Month
+14.0%
+14.0%
3 Month
+70.8%
+70.8%
6 Month
+52.5%
+52.5%
1 Year
+2.3%
+2.3%

More News

Read More
CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
October 01, 2025
From SkyMedia, LLC
Via GlobeNewswire
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
October 01, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
October 01, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 01, 2025
Via Benzinga
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
September 30, 2025
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
September 30, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
September 30, 2025
Via NewMediaWire
Topics Fraud Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
September 30, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
September 30, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
September 30, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
September 30, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
Lost Money on Cytokinetics, Incorporated (CYTK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
September 29, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Lost Money on Cytokinetics, Incorporated (CYTK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
September 29, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
September 28, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
Lost Money on Cytokinetics, Incorporated (CYTK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
September 26, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Lost Money on Cytokinetics, Incorporated (CYTK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
September 26, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
September 25, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
September 25, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
September 25, 2025
From SkyMedia, LLC
Via GlobeNewswire
Faruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
September 25, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
September 24, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK
September 24, 2025
From Pomerantz LLP
Via GlobeNewswire
Deadline Alert: Cytokinetics, Incorporated (CYTK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
September 24, 2025
From Glancy Prongay & Murray LLP
Via Business Wire

Frequently Asked Questions

Is Cytokinetics, Incorporated - Common Stock publicly traded?
Yes, Cytokinetics, Incorporated - Common Stock is publicly traded.
What exchange does Cytokinetics, Incorporated - Common Stock trade on?
Cytokinetics, Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytokinetics, Incorporated - Common Stock?
The ticker symbol for Cytokinetics, Incorporated - Common Stock is CYTK on the Nasdaq Stock Market
What is the current price of Cytokinetics, Incorporated - Common Stock?
The current price of Cytokinetics, Incorporated - Common Stock is 56.97
When was Cytokinetics, Incorporated - Common Stock last traded?
The last trade of Cytokinetics, Incorporated - Common Stock was at 10/03/25 04:00 PM ET
What is the market capitalization of Cytokinetics, Incorporated - Common Stock?
The market capitalization of Cytokinetics, Incorporated - Common Stock is 5.45B
How many shares of Cytokinetics, Incorporated - Common Stock are outstanding?
Cytokinetics, Incorporated - Common Stock has 5B shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.45
+0.02 (0.01%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap